Insider Transactions in Q1 2021 at Gt Biopharma, Inc. (GTBP)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2021
|
Michael Martin Breen Executive Chairman/Interim CEO |
BUY
Conversion of derivative security
|
Direct |
50,102
+7.07%
|
$150,306
$3.4 P/Share
|
|
Feb 16
2021
|
Gregory Berk Pres. of R&D, CMO |
BUY
Grant, award, or other acquisition
|
Direct |
278,058
+50.0%
|
-
|
|
Feb 16
2021
|
Michael Martin Breen Executive Chairman/Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
278,058
+50.0%
|
-
|
|
Feb 16
2021
|
Bruce Wendel Director |
BUY
Grant, award, or other acquisition
|
Direct |
347,572
+49.64%
|
-
|